Symbols

PCSA

Processa·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 0

Ample Liquidity

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About PCSA

Processa Pharmaceuticals, Inc.

A clinical stage biopharmaceutical company that develops products for cancers

Industry

Pharmaceutical

Established Date

03/29/2011

Listing Date

10/02/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.processapharmaceuticals.com

Security Type

Common stock

Office address

601 21st Street, Suite 300 Vero Beach, FL 32960

Business

Introduction

Processa Pharmaceuticals, Inc., was founded on March 29, 2011. The company is a clinical-stage biopharmaceutical company developing a next-generation pipeline of small molecules for cancer therapy, two of which are in or have completed Phase 2 trials and one is in preclinical development.

Company Financials

EPS

PCSA has released its 2025 Q3 earnings. EPS was reported at -0.07, versus the expected -0.45, beating expectations. The chart below visualizes how PCSA has performed over recent quarters, highlighting trends in earnings surprises.